StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
42
This year
5
Publishing Date
2024 - 03 - 15
1
2024 - 02 - 22
1
2024 - 02 - 14
1
2024 - 02 - 12
1
2024 - 02 - 06
1
2023 - 12 - 08
1
2023 - 11 - 02
1
2023 - 07 - 20
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 16
1
2023 - 06 - 08
1
2023 - 05 - 15
1
2023 - 04 - 27
1
2023 - 04 - 18
1
2023 - 04 - 04
1
2023 - 03 - 06
1
2023 - 01 - 23
1
2023 - 01 - 19
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 12
1
2022 - 11 - 10
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 13
1
2022 - 06 - 23
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 17
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 03 - 21
1
2022 - 01 - 07
1
2021 - 11 - 12
1
2021 - 10 - 04
1
2021 - 08 - 25
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 07 - 20
1
Sector
Health technology
42
Manufacturing
12
N/a
2
Process industries
1
Professional, scientific, and technical services
2
Tags
Alzheimer's
1
Alzheimer’s
1
Antibody
2
Biopharma
1
Biotech
2
Blood
1
Business
2
Cancer
7
Cell
1
China
3
Clinical-trials-phase-iii
1
Companies
1
Depression
2
Designation
1
Diagnostics
1
Disease
6
Drug
2
Earnings
1
Expansion
1
Expected
2
Financial
1
Gene therapies
1
Gene therapy
1
Global
12
Growing
2
Growth
9
Hormone
1
Iot
2
Lancet
1
License
1
Life
1
Liver
1
Lung
1
Market
26
Metabolic
1
N/a
39
Pharm-country
1
Protein
1
Publication
1
Reach
2
Report
14
Research
5
Results
2
Study
1
System
1
T-cell
1
Technology
2
Therapeutics
6
Therapy
4
Treat
1
Treatment
10
Trial
1
Ulcerative colitis
1
Vaccine
1
Entities
Abbott laboratories
10
Abbvie inc.
31
Adma biologics inc
4
Adverum biotechnologies, inc.
2
Agios pharmaceuticals, inc.
2
Alnylam pharmaceuticals, inc.
2
Altria group
2
Amgen inc.
23
Amicus therapeutics, inc.
2
Arcturus therapeutics holdings inc.
26
Arrowhead pharmaceuticals, inc.
12
Astellas pharma inc
12
Astrazeneca plc
29
Avalonbay communities, inc.
2
Bausch health companies inc.
7
Baxter international inc.
5
Biocryst pharmaceuticals, inc.
2
Biogen inc.
6
Bristol-myers squibb company
43
Catalent, inc.
3
Centogene n.v.
5
Codexis, inc.
3
Csl ltd
4
Eli lilly and company
42
Exelixis, inc.
27
Genmab a/s
3
Gilead sciences, inc.
15
Glaxosmithkline plc
34
Global blood therapeutics, inc.
3
Grifols, s.a.
6
Hutchison china meditech limited
7
Immunogen, inc.
3
Incyte corporation
16
Jazz pharmaceuticals plc
6
Johnson & johnson
82
Karyopharm therapeutics inc.
7
Logicbio therapeutics, inc.
4
Macrogenics, inc.
4
Mallinckrodt plc
4
Moderna, inc.
5
Morphosys ag
13
Nektar therapeutics
3
Neurocrine biosciences, inc.
9
Novartis ag
58
Novavax, inc.
4
Novo nordisk a/s
15
Orange
4
Ovid therapeutics inc.
6
Pfizer, inc.
23
Regeneron pharmaceuticals, inc.
6
Sanofi
60
Takeda pharmaceutical company limited
421
Teva pharmaceutical industries limited
5
Teva pharmaceutical industries ltd
20
Thermo fisher scientific inc
7
Ucb s.a.
8
Vericel corporation
3
Vertex pharmaceuticals incorporated
4
Viatris inc.
7
Xencor, inc.
12
Symbols
ABBV
111
ABCL
12
ABT
56
ACIU
35
ADCT
13
AKUS
11
ALNY
38
ALPMF
25
ALPMY
25
AMGN
88
AVEO
25
AZN
98
AZNCF
81
BAX
14
BCRX
13
BDX
21
BGNE
19
BIIB
20
BMY
106
BNTX
14
BPMC
20
CLVS
20
DTIL
11
EPZM
20
EXEL
13
GILD
35
GLAXF
80
GSK
107
HCM
11
ILMN
15
INCY
207
JNJ
175
KPTI
20
LLY
1709
MDT
14
MRUS
21
NVO
83
NVS
138
NVSEF
121
OMER
15
OTIC
13
PFE
80
PODD
14
PRQR
17
REGN
36
RIGL
41
SNY
335
SNYNF
253
TAK
42
TEVJF
61
TMO
14
TRUMF
14
TRUMY
14
UCBJF
11
UCBJY
11
UTHR
14
VERU
57
VRTX
12
VTRS
18
YMAB
18
Exchanges
Nasdaq
39
Nyse
42
Crawled Date
2024 - 03 - 15
1
2024 - 02 - 22
1
2024 - 02 - 14
1
2024 - 02 - 12
1
2024 - 02 - 07
1
2023 - 12 - 08
1
2023 - 11 - 02
1
2023 - 07 - 20
1
2023 - 06 - 30
1
2023 - 06 - 27
1
2023 - 06 - 16
1
2023 - 06 - 08
1
2023 - 05 - 15
1
2023 - 04 - 28
1
2023 - 04 - 18
1
2023 - 04 - 04
1
2023 - 03 - 06
1
2023 - 01 - 23
1
2023 - 01 - 19
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 12
1
2022 - 11 - 10
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 07 - 13
1
2022 - 06 - 23
1
2022 - 06 - 14
1
2022 - 06 - 02
1
2022 - 05 - 17
1
2022 - 04 - 26
1
2022 - 04 - 12
1
2022 - 03 - 21
1
2022 - 01 - 07
1
2021 - 11 - 12
1
2021 - 10 - 04
1
2021 - 08 - 25
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 07 - 20
1
Crawled Time
00:00
3
01:00
4
02:00
3
04:00
1
08:00
2
10:00
5
11:00
2
12:00
1
13:00
3
13:20
1
14:00
1
14:30
1
15:15
1
15:20
1
16:00
1
17:00
1
18:00
1
19:00
3
20:00
2
21:00
2
22:00
1
23:00
2
Source
www.biospace.com
3
www.globenewswire.com
2
www.prnewswire.com
37
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Eli lilly and company
symbols :
Tak
save search
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.67%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.84%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.01%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.52%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.71%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.4%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.49%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.96%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.13%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
7.24%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
26.78%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-14.57%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-10.18%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.0%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-5.22%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.63%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-3.89%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-5.63%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.76%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
5.32%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.13%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published:
2024-02-14
(Crawled : 02:00)
- prnewswire.com
LZAGF
|
$563.5
-19.1%
6
|
Health Technology
|
9.6%
|
O:
3.14%
H:
1.92%
C:
1.92%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.81%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
10.28%
|
O:
0.87%
H:
0.21%
C:
-2.23%
LZAGY
|
$55.65
0.02%
32K
|
Professional, Scientific, and T...
|
11.08%
|
O:
4.07%
H:
1.53%
C:
1.45%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
1.15%
|
O:
0.56%
H:
1.3%
C:
1.22%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.67%
|
O:
0.42%
H:
1.04%
C:
0.97%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.21%
|
O:
-0.91%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.96%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.24%
|
O:
0.38%
H:
2.44%
C:
1.54%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-0.38%
|
O:
0.33%
H:
0.63%
C:
-0.28%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-4.61%
|
O:
-0.73%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.7%
|
O:
-0.83%
H:
0.66%
C:
0.38%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.28%
|
O:
-1.1%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$29.095
0.64%
0.64%
87K
|
Health Technology
|
-25.55%
|
O:
-1.72%
H:
1.8%
C:
1.59%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-14.24%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
12.32%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-7.42%
|
O:
-0.21%
H:
0.34%
C:
0.07%
report
global
protein
growth
market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published:
2024-02-12
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-1.6%
|
O:
3.52%
H:
0.0%
C:
-1.18%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
12.87%
|
O:
0.06%
H:
2.34%
C:
2.29%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.2%
|
O:
0.37%
H:
0.74%
C:
0.28%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.48%
|
O:
0.14%
H:
0.35%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.14%
|
O:
-0.34%
H:
0.23%
C:
-1.13%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.55%
|
O:
0.7%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-3.21%
|
O:
1.22%
H:
0.07%
C:
-0.43%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-1.49%
|
O:
-0.96%
H:
1.75%
C:
1.75%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-1.65%
|
O:
-0.18%
H:
0.48%
C:
-1.91%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-3.85%
|
O:
0.8%
H:
0.0%
C:
0.0%
ZLAB
|
$14.08
-0.99%
-0.99%
470K
|
Health Technology
|
-22.73%
|
O:
-1.15%
H:
1.03%
C:
-1.5%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.79%
|
O:
-0.28%
H:
0.49%
C:
-0.32%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.22%
|
O:
-0.06%
H:
0.0%
C:
0.0%
IPHA
|
$2.48
5.53%
5.24%
9.4K
|
Health Technology
|
-5.43%
|
O:
-3.1%
H:
1.2%
C:
-0.8%
INCY
|
$52.3
-0.98%
-0.99%
2.2M
|
Health Technology
|
-9.49%
|
O:
3.8%
H:
1.1%
C:
-1.17%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-20.58%
|
O:
-3.72%
H:
0.58%
C:
-3.82%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
11.63%
|
O:
-0.26%
H:
0.73%
C:
-0.36%
ARGX
|
$360.11
0.47%
0.47%
330K
|
Health Technology
|
-8.27%
|
O:
-2.3%
H:
1.65%
C:
0.83%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-8.66%
|
O:
0.06%
H:
0.31%
C:
-1.4%
expansion
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-12.32%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
1.76%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
38.0%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-12.76%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-6.5%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.04%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.03%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
3.02%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-0.67%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-2.7%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-5.25%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-0.49%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$109.96
0.63%
0.63%
760K
|
Health Technology
|
-11.84%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
2.25%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-14.91%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published:
2023-12-08
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-21.02%
|
O:
-2.79%
H:
0.62%
C:
0.62%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
2.34%
|
O:
2.06%
H:
0.82%
C:
0.82%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.34%
|
O:
-1.29%
H:
0.4%
C:
0.4%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-22.51%
|
O:
-2.2%
H:
0.0%
C:
-0.27%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-5.97%
|
O:
-0.64%
H:
0.5%
C:
0.5%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
26.75%
|
O:
-0.42%
H:
0.67%
C:
0.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.64%
|
O:
0.19%
H:
0.35%
C:
0.2%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.17%
|
O:
-0.18%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
23.82%
|
O:
0.43%
H:
0.0%
C:
0.0%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-2.45%
|
O:
0.2%
H:
0.55%
C:
0.1%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
12.6%
|
O:
0.3%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.27%
|
O:
1.07%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.47%
|
O:
0.08%
H:
1.45%
C:
1.17%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.88%
|
O:
-0.05%
H:
0.3%
C:
-0.76%
reach
market
ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results
Published:
2023-11-02
(Crawled : 13:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-3.0%
|
O:
1.03%
H:
0.73%
C:
0.58%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
31.44%
|
O:
4.42%
H:
0.0%
C:
0.0%
IMGN
|
$31.23
0.03%
49M
|
Health Technology
|
109.1%
|
O:
5.09%
H:
5.48%
C:
-1.27%
financial
results
HUTCHMED Receives Breakthrough Therapy Designation in China for Fruquintinib Combination with Sintilimab for Treatment of Advanced Endometrial Cancer, and Completes Enrollment of Registration Study
Published:
2023-07-20
(Crawled : 00:00)
- globenewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-14.25%
|
O:
-0.65%
H:
0.49%
C:
0.07%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
60.14%
|
O:
0.35%
H:
2.21%
C:
1.9%
HCM
|
$16.49
0.8%
0.79%
61K
|
Health Technology
|
35.25%
|
O:
-0.33%
H:
2.55%
C:
1.4%
treatment
designation
china
therapy
study
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published:
2023-06-30
(Crawled : 23:00)
- prnewswire.com
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
Email alert
Add to watchlist
UCBJF
|
$126.05
-39.66%
100
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
report
business
life
global
therapeutics
Global Cancer Therapies Strategic Business Report 2023: Industry Focuses on New Approaches to Treat Cancer
Published:
2023-06-27
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
11.2%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-16.04%
|
O:
-0.95%
H:
0.19%
C:
-0.32%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-29.52%
|
O:
0.19%
H:
0.11%
C:
-1.46%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.18%
|
O:
-0.01%
H:
0.16%
C:
-0.32%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.61%
|
O:
0.03%
H:
0.12%
C:
-0.24%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
9.59%
|
O:
-0.91%
H:
0.56%
C:
-0.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
60.42%
|
O:
2.15%
H:
1.18%
C:
0.43%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.48%
|
O:
-0.06%
H:
0.46%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-4.43%
|
O:
-0.21%
H:
0.42%
C:
0.13%
report
business
cancer
treat
global
Takeda and HUTCHMED Announce Publication of Phase 3 FRESCO-2 Results in The Lancet
Published:
2023-06-16
(Crawled : 10:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.02%
|
O:
-0.06%
H:
0.53%
C:
-0.31%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
60.0%
|
O:
0.41%
H:
0.26%
C:
-1.77%
lancet
publication
results
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published:
2023-06-08
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-7.28%
|
O:
0.07%
H:
0.0%
C:
-1.7%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.25%
|
O:
1.32%
H:
0.0%
C:
-0.62%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.71%
|
O:
-0.62%
H:
0.88%
C:
0.81%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.2%
|
O:
1.26%
H:
1.08%
C:
0.91%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
15.69%
|
O:
0.41%
H:
0.68%
C:
0.64%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
66.44%
|
O:
-0.11%
H:
2.66%
C:
2.24%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-24.91%
|
O:
0.28%
H:
0.42%
C:
-0.05%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-20.66%
|
O:
0.39%
H:
0.15%
C:
-0.79%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-6.49%
|
O:
-0.23%
H:
1.83%
C:
1.52%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
21.55%
|
O:
0.0%
H:
0.28%
C:
-0.23%
metabolic
report
cancer
global
therapeutics
growth
market
Global Acute Repetitive Seizures Market to Showcase Promising Growth says Brandessence Market Research
Published:
2023-05-15
(Crawled : 10:00)
- prnewswire.com
UCBJY
|
$63.676
-4.38%
7.2K
|
Manufacturing
|
39.83%
|
O:
1.79%
H:
0.18%
C:
-0.06%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-19.17%
|
O:
0.61%
H:
0.3%
C:
0.24%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.0%
|
O:
0.01%
H:
0.14%
C:
-0.78%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
67.19%
|
O:
0.22%
H:
0.14%
C:
-0.2%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
13.09%
|
O:
0.35%
H:
0.83%
C:
-0.73%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
13.49%
|
O:
0.17%
H:
1.07%
C:
0.19%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.4%
|
O:
0.38%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-14.6%
|
O:
-0.13%
H:
0.42%
C:
0.4%
research
global
growth
market
Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report 2023: New Drug Launches and Growing Awareness Fuels $32 Billion Industry
Published:
2023-04-27
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.12%
|
O:
0.23%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-21.47%
|
O:
-1.13%
H:
0.3%
C:
-0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.08%
|
O:
-0.79%
H:
0.89%
C:
0.72%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.26%
|
O:
-0.12%
H:
0.58%
C:
0.55%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
10.39%
|
O:
-0.25%
H:
0.97%
C:
0.31%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
86.07%
|
O:
1.96%
H:
1.59%
C:
-0.54%
drug
report
treatment
global
growing
market
HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer
Published:
2023-04-18
(Crawled : 01:00)
- globenewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-20.62%
|
O:
0.9%
H:
0.0%
C:
-0.71%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
95.06%
|
O:
0.17%
H:
0.34%
C:
-0.83%
HCM
|
$16.49
0.8%
0.79%
61K
|
Health Technology
|
-1.79%
|
O:
1.49%
H:
2.64%
C:
1.52%
china
Global Depression Treatment Market to 2030: Rising Prevalence of Psychiatric Diseases and Development of Innovative Medications for Treatment-resistant Depression Drives Growth
Published:
2023-04-04
(Crawled : 02:00)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-19.85%
|
O:
-0.12%
H:
1.55%
C:
1.03%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
107.08%
|
O:
0.38%
H:
1.97%
C:
0.72%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-29.79%
|
O:
0.13%
H:
0.0%
C:
-1.25%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-14.91%
|
O:
-0.1%
H:
0.0%
C:
0.0%
depression
treatment
global
growth
market
Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published:
2023-03-06
(Crawled : 20:00)
- prnewswire.com
CMXHF
|
$172.54
-19.21%
50
|
n/a
|
-10.86%
|
O:
-0.86%
H:
0.33%
C:
0.33%
CSLLY
|
$86.918
3.3%
60K
|
n/a
|
-12.35%
|
O:
-0.02%
H:
0.54%
C:
-1.7%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
4.61%
|
O:
-2.57%
H:
1.62%
C:
1.62%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-2.46%
|
O:
0.41%
H:
0.39%
C:
-2.14%
TEVA
|
$12.86
0.63%
0.0%
10M
|
Health Technology
|
29.77%
|
O:
-1.21%
H:
0.43%
C:
-3.58%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-15.35%
|
O:
0.83%
H:
0.06%
C:
-1.2%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-16.67%
|
O:
0.76%
H:
1.91%
C:
1.26%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
15.38%
|
O:
0.32%
H:
0.17%
C:
-1.53%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
127.71%
|
O:
0.01%
H:
0.42%
C:
-2.62%
CTLT
|
$55.48
-0.57%
-0.4%
1.6M
|
Health Technology
|
-22.23%
|
O:
0.11%
H:
0.53%
C:
-5.05%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-28.98%
|
O:
0.41%
H:
0.04%
C:
-1.71%
ALB
|
$112.15
0.31%
-0.13%
2M
|
Process Industries
|
-56.34%
|
O:
-0.95%
H:
1.02%
C:
-2.19%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
7.17%
|
O:
0.19%
H:
0.06%
C:
-1.7%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.0%
|
O:
0.65%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-17.69%
|
O:
0.23%
H:
0.0%
C:
-1.25%
BIIB
|
$194.39
2.03%
1.99%
1.6M
|
Health Technology
|
-28.07%
|
O:
0.28%
H:
0.0%
C:
-2.26%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
6.18%
|
O:
0.9%
H:
0.28%
C:
-1.3%
global
report
market
HUTCHMED Announces License to Takeda to Develop and Commercialize Fruquintinib Outside China
Published:
2023-01-23
(Crawled : 10:00)
- biospace.com/
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.62%
|
O:
-0.25%
H:
0.4%
C:
-0.25%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
109.87%
|
O:
0.16%
H:
0.0%
C:
-1.27%
license
china
Global Prescription Drugs Market Analysis Report 2022: Increasing Number of Chronic Diseases Worldwide will Continue to Fuel Growth - Forecast to 2027
Published:
2023-01-19
(Crawled : 17:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.14%
|
O:
0.69%
H:
0.0%
C:
-1.52%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-4.71%
|
O:
1.26%
H:
1.19%
C:
1.19%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-17.97%
|
O:
-0.31%
H:
1.15%
C:
0.68%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-12.2%
|
O:
0.13%
H:
0.65%
C:
0.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.39%
|
O:
-0.1%
H:
0.31%
C:
0.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-12.87%
|
O:
-0.43%
H:
1.33%
C:
0.3%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
12.96%
|
O:
0.17%
H:
1.36%
C:
1.02%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
106.33%
|
O:
0.1%
H:
0.97%
C:
-0.37%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-32.17%
|
O:
0.29%
H:
2.1%
C:
1.94%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
11.53%
|
O:
-0.17%
H:
1.07%
C:
-0.16%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-6.95%
|
O:
-0.92%
H:
0.0%
C:
0.0%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-20.28%
|
O:
0.51%
H:
0.49%
C:
-0.65%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
1.72%
|
O:
-0.9%
H:
0.58%
C:
0.01%
global
report
growth
market
LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published:
2023-01-18
(Crawled : 12:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-94.91%
|
O:
-0.13%
H:
3.25%
C:
-3.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.02%
|
O:
0.62%
H:
0.12%
C:
-0.68%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-43.58%
|
O:
-1.16%
H:
0.67%
C:
-1.2%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.14%
|
O:
0.93%
H:
0.01%
C:
-1.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.19%
|
O:
-0.41%
H:
0.2%
C:
-1.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
103.03%
|
O:
-0.4%
H:
0.75%
C:
-1.21%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
-26.65%
|
O:
0.07%
H:
2.69%
C:
0.32%
market
← Previous
1
2
3
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.